Glaucoma

As technology improves, less-invasive treatments save patients time and money.

Mitch Ibach, OD, FAAO, shares highlights from his VEW 2022 presentation, "Visual fields, a virtual reality."

Melissa Barnett, OD, from the University of California, Davis Eye Center, Sacramento and Davis, CA, described new strategies, technologies, and drug classes to treat chronic conditions that include myopia, Demodex infestation, meibomian gland dysfunction, glaucoma drug delivery, advancements in corneal and cataract surgeries, and presbyopia

Optometrists are seeing recent advances in topical therapies that entered the market following decades of reliance of traditional single-agent drops. An implantable device that facilitates the slow release of drug is changing the landscape in glaucoma therapy.

Justin Schweitzer, OD, FAAO, reports that glaucoma therapy is quickly moving to more innovative and targeted ways to treat glaucoma and lower the patient treatment burden.

Michael Chaglasian, OD, Illinois College of Optometry, Chicago, and Eric Schmidt, OD, Omni Eye Specialists, Wilmington, NC, share guidelines for ODs on diagnosing glaucoma during the 2022 Vision Expo West in Las Vegas.

Jessica Steen, OD, FAAO, shares highlights from her VEW 2022 presentation, "Ophthalmic therapeutics update."

Leo P. Semes, OD, FAAO, discusses his presentation on, "When glaucoma isn't glaucoma," during the South Carolina Optometric Physicians Association's annual meeting.

Glaucoma search study finds online medical resources lack readability.

A 35-year-old woman presents with ptosis of the right eyelid 4 days after undergoing injection of botulinum toxin type A.

A growing number of less complex and invasive treatments are offering ODs more options for patient care.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part four.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part three.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part two.

4 objectives are key for embracing a patient-focused form of care.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part one.

Knowing your glaucoma vitals is key to providing best treatment for patients.

Examine the anterior segment for risk factor identification and early diagnosis.

Justin Schweitzer, OD, shares key highlights from his presentation titled, "The OD's Role in the Management of MIGS in 2022," where he explores earlier intervention for glaucoma patients.

Vin Dang, OD, FAAO, and Jacob Lang, OD, FAAO, speak on the highlights and key takeaways from their AOA 2022 lecture titled "Ocular surface preservation for the glaucoma patient."

Investigators from the Sun Yay-Sen University in Guangzhou have created a theranostic device that targets sensing rising fluid pressures within the eye to automatically deliver medication for a glaucoma patient.

Optometrists can play an important role in early detection, earlier surgical referral to experienced skillful surgeons, surveillance, and follow-up care for glaucoma patients.

This far-less-understood option can fill multiple needs for a practice.

Four patients present with previously undiagnosed conditions.

Research to Prevent Blindness will launch the RPB/David L. Epstein Career Advancement Award in Glaucoma Research, sponsored by Aerie Pharmaceuticals.